GoodRx Inc.

2 days ago · seekingalpha.com

GoodRx Holdings remains a 'buy' as shares are deeply undervalued despite recent operational headwinds and a 45% stock decline. Revenue and profits grew through 2025, but 2026 saw declines due to falling monthly active users and retail pharmacy disruptions. Strategic investments in subscriptions and Pharma Direct, especially weight loss drugs, are driving growth in new segments despite short-term margin pressure.

1 month ago · reuters.com

Amazon.com , GoodRx and other companies offering online subscriptions that charge a flat fee for prescription drugs and other health services are reaping the ​benefits of Americans looking to combat rising costs and dwindling health insurance options.

2 months ago · pymnts.com

Prescription platform GoodRx has launched a new plan that covers a primary member and up to four dependents, including children, adult family members and pets, the company said in a Thursday (Sept. 3) press release.

3 months ago · seekingalpha.com

GoodRx has rebounded from $2.50 per share, showing renewed growth momentum and improved consumer traction. New offerings have contributed to GDRX's recent positive developments, but the stock's rapid appreciation reflects these improvements. I remain marginally more positive, yet GDRX still presents considerable risk, warranting a continued neutral rating.

3 months ago · seekingalpha.com

GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript

3 months ago · marketbeat.com

GoodRx NASDAQ: GDRX reported second-quarter 2026 revenue of $200.4 million and adjusted EBITDA of $63.7 million, representing a 31.8% adjusted EBITDA margin, as growth in its Pharma Direct and subscription businesses offset pressure in prescription transaction revenue.

3 months ago · pymnts.com

The latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year earnings Thursday (Aug. 6) showing record profitability for the first six months of 2026, with revenues surging 70% to $4.9 billion.

3 months ago · zacks.com

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.

3 months ago · zacks.com

The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

4 months ago · businesswire.com

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's bus.